Quintiles’ HTA Watch is a web-based service offering instant access to a global repository of published HTA reports from nearly 100 agencies in 32 countries, providing regularly updated assessments to help inform life sciences and healthcare companies’ strategic decision-making*

In this edition of our HTA uncovered series, we'll explore Real world evidence and collecting the right data to satisfy multiple stakeholder needs plus payers’ perspectives on endpoints in oncology trials.

Click here for the March edition

* Any assessments or evaluations are provided by Quintiles as a service for information purposes only, and are based on the HTA reports referenced above.